Modulation by Glycine on Vascular Effect of NMDA: in Vivo Experimental Researches

Overview

Journal Amino Acids

Specialty Biochemistry

Date 2013 Nov 6

PMID 24190564

Authors

L Berrino

S Vitagliano

S Maione

F Rossi

Affiliations

Soon will be listed here.

Abstract

The present study has been carried out to determine if glycine, an allosteric modulator of NMDA receptor, is involved in the vascular effect induced by the activation of the CNS NMDA receptors.Icv NMDA (from 0.01 to 1µg/rat in the 3rd ventricle) determined a significant increase in arterial blood pressure in conscious freely moving rats. Moreover, the hypertension was associated with behavioural modifications (jumping, rearing, teething and running). Glycine pretreatment (1 and 10µg/raticv), significantly increased the NMDA hypertension. Alone glycine did not cause any arterial blood pressure modification while it induced a slight sedation. HA-966 (an antagonist of the glycine site on NMDA receptor) administration (1-10µg/raticv 5 min before glycine) significantly antagonized the glycine effects on NMDA hypertension.Alone HA-966 neither modified arterial blood pressure nor antagonized NMDA hypertension. In conclusion, our investigations confirm NMDA receptor involvement in cardiovascular function and they demonstrate that in vivo glycine positively modulates NMDA receptor.

References

Koek W, Colpaert F . Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther. 1990; 252(1):349-57. View

Kaplita P, Ferkany J . Evidence for direct interactions between the NMDA and glycine recognition sites in brain. Eur J Pharmacol. 1990; 188(2-3):175-9. DOI: 10.1016/0922-4106(90)90053-z. View

White W, Brown K, Frank D . Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites. J Neurochem. 1989; 53(2):503-12. DOI: 10.1111/j.1471-4159.1989.tb07362.x. View

Schmidt C, Taylor V . Strychnine-sensitive, glycine-induced release of [3H]norepinephrine from rat hippocampal slices. J Neurochem. 1990; 54(6):2077-81. DOI: 10.1111/j.1471-4159.1990.tb04913.x. View

Berrino L, Matera M, Maione S, Vitagliano S, Loffreda A, MARMO E . Excitatory amino acids and cardiovascular apparatus: experimental studies on conscious rats with L-glutamate, N-methyl-D-aspartate, kainate and quisqualate. Acta Physiol Hung. 1990; 75 Suppl:31-2. View

Young A, Snyder S . Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A. 1973; 70(10):2832-6. PMC: 427119. DOI: 10.1073/pnas.70.10.2832. View

Lampa E, Cazzola M, Angrisani M, Matera C, Lisa M, SUSANNA V . Cardiovascular effects of intracerebral injections of glutamate and kainate in rats. Zhongguo Yao Li Xue Bao. 1988; 9(3):252-7. View

Salt T . Modulation of NMDA receptor-mediated responses by glycine and D-serine in the rat thalamus in vivo. Brain Res. 1989; 481(2):403-6. DOI: 10.1016/0006-8993(89)90823-8. View

Raiteri M, Fontana G, Fedele E . Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus. Eur J Pharmacol. 1990; 184(2-3):239-50. DOI: 10.1016/0014-2999(90)90615-d. View

10.

Pittaluga A, Raiteri M . Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol. 1990; 191(2):231-4. DOI: 10.1016/0014-2999(90)94153-o. View

11.

Toth E, Lajtha A . Motor effects of intracaudate injection of excitatory amino acids. Pharmacol Biochem Behav. 1989; 33(1):175-9. DOI: 10.1016/0091-3057(89)90447-4. View

12.

Henderson G, Johnson J, Ascher P . Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. J Physiol. 1990; 430:189-212. PMC: 1181734. DOI: 10.1113/jphysiol.1990.sp018288. View

13.

Maione S, Vitagliano S, Berrino L, Lampa E, Rossi F . Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats. Neuropharmacology. 1992; 31(4):403-7. DOI: 10.1016/0028-3908(92)90074-y. View

14.

Lampa E, Berrino L, SUSANNA V, Angrisani M, Marrazzo R, Maione S . Glutamergic transmission and cardiovascular apparatus in normotensive rats. Drugs Exp Clin Res. 1988; 14(1):59-69. View

15.

Vamvakides A . [Some pharmacologic comments on the action of glycine derivatives in relation to peculiarities of the central glycinergic system]. Agressologie. 1989; 30(8):465-6. View